NCT00003715 2015-12-03
Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
AVAX Technologies
Phase 2 Terminated
Clinical Trials
3 trialsNCT00436930 2014-01-10
Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004022 2013-04-05
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed